These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 31578419)

  • 1. New screening approach for Alzheimer's disease risk assessment from urine lipid peroxidation compounds.
    Peña-Bautista C; Vigor C; Galano JM; Oger C; Durand T; Ferrer I; Cuevas A; López-Cuevas R; Baquero M; López-Nogueroles M; Vento M; Hervás-Marín D; García-Blanco A; Cháfer-Pericás C
    Sci Rep; 2019 Oct; 9(1):14244. PubMed ID: 31578419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma lipid peroxidation biomarkers for early and non-invasive Alzheimer Disease detection.
    Peña-Bautista C; Vigor C; Galano JM; Oger C; Durand T; Ferrer I; Cuevas A; López-Cuevas R; Baquero M; López-Nogueroles M; Vento M; Hervás D; García-Blanco A; Cháfer-Pericás C
    Free Radic Biol Med; 2018 Aug; 124():388-394. PubMed ID: 29969716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of lipid peroxidation and artificial neural network models in early Alzheimer Disease diagnosis.
    Peña-Bautista C; Durand T; Oger C; Baquero M; Vento M; Cháfer-Pericás C
    Clin Biochem; 2019 Oct; 72():64-70. PubMed ID: 31319065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliable determination of new lipid peroxidation compounds as potential early Alzheimer Disease biomarkers.
    García-Blanco A; Peña-Bautista C; Oger C; Vigor C; Galano JM; Durand T; Martín-Ibáñez N; Baquero M; Vento M; Cháfer-Pericás C
    Talanta; 2018 Jul; 184():193-201. PubMed ID: 29674032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid peroxidation biomarkers correlation with medial temporal atrophy in early Alzheimer Disease.
    Peña-Bautista C; López-Cuevas R; Cuevas A; Baquero M; Cháfer-Pericás C
    Neurochem Int; 2019 Oct; 129():104519. PubMed ID: 31398364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma isoprostanoids assessment as Alzheimer's disease progression biomarkers.
    Peña-Bautista C; Álvarez L; Baquero M; Ferrer I; García L; Hervás-Marín D; Cháfer-Pericás C
    J Neurochem; 2021 Jun; 157(6):2187-2194. PubMed ID: 32918484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Utility of Plasma Lipid Peroxidation Biomarkers in Alzheimer's Disease Differential Diagnosis.
    Peña-Bautista C; Álvarez L; Durand T; Vigor C; Cuevas A; Baquero M; Vento M; Hervás D; Cháfer-Pericás C
    Antioxidants (Basel); 2020 Jul; 9(8):. PubMed ID: 32707935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer's Disease.
    Peña-Bautista C; Baquero M; López-Nogueroles M; Vento M; Hervás D; Cháfer-Pericás C
    Antioxidants (Basel); 2020 May; 9(5):. PubMed ID: 32397687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropsychological assessment and cortisol levels in biofluids from early Alzheimer's disease patients.
    Peña-Bautista C; Baquero M; Ferrer I; Hervás D; Vento M; García-Blanco A; Cháfer-Pericás C
    Exp Gerontol; 2019 Aug; 123():10-16. PubMed ID: 31117002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Lipid Peroxidation in Alzheimer's Disease Differential Diagnosis and Prognosis.
    Ferré-González L; Peña-Bautista C; Baquero M; Cháfer-Pericás C
    Antioxidants (Basel); 2022 Mar; 11(3):. PubMed ID: 35326200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases.
    Montine KS; Quinn JF; Zhang J; Fessel JP; Roberts LJ; Morrow JD; Montine TJ
    Chem Phys Lipids; 2004 Mar; 128(1-2):117-24. PubMed ID: 15037157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validated analytical method to determine new salivary lipid peroxidation compounds as potential neurodegenerative biomarkers.
    Peña-Bautista C; Carrascosa-Marco P; Oger C; Vigor C; Galano JM; Durand T; Baquero M; López-Nogueroles M; Vento M; García-Blanco A; Cháfer-Pericás C
    J Pharm Biomed Anal; 2019 Feb; 164():742-749. PubMed ID: 30476862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A ultra-pressure liquid chromatography/triple quadrupole tandem mass spectrometry method for the analysis of 13 eicosanoids in human urine and quantitative 24 hour values in healthy volunteers in a controlled constant diet.
    Medina S; Domínguez-Perles R; Gil JI; Ferreres F; García-Viguera C; Martínez-Sanz JM; Gil-Izquierdo A
    Rapid Commun Mass Spectrom; 2012 May; 26(10):1249-57. PubMed ID: 22499201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential applications of lipid peroxidation products - F
    De Las Heras-Gómez I; Medina S; Casas-Pina T; Marín-Soler L; Tomás A; Martínez-Hernández P; Oger C; Galano JM; Durand T; Jimeno L; Llorente S; Lozoya E; Ferreres F; Gil-Izquierdo Á
    Free Radic Biol Med; 2017 Mar; 104():178-184. PubMed ID: 28089724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples.
    Leung KS; Galano JM; Durand T; Lee JC
    Free Radic Res; 2015; 49(7):816-26. PubMed ID: 25184341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid peroxidation in aging brain and Alzheimer's disease.
    Montine TJ; Neely MD; Quinn JF; Beal MF; Markesbery WR; Roberts LJ; Morrow JD
    Free Radic Biol Med; 2002 Sep; 33(5):620-6. PubMed ID: 12208348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snapshot situation of oxidative degradation of the nervous system, kidney, and adrenal glands biomarkers-neuroprostane and dihomo-isoprostanes-urinary biomarkers from infancy to elderly adults.
    García-Flores LA; Medina S; Martínez-Hernández P; Oger C; Galano JM; Durand T; Casas-Pina T; Ferreres F; Gil-Izquierdo Á
    Redox Biol; 2017 Apr; 11():586-591. PubMed ID: 28110214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.
    Anand S; Barnes JM; Young SA; Garcia DM; Tolley HD; Kauwe JSK; Graves SW
    J Alzheimers Dis; 2017; 59(1):277-290. PubMed ID: 28598845
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihomo-isoprostanes-nonenzymatic metabolites of AdA-are higher in epileptic patients compared to healthy individuals by a new ultrahigh pressure liquid chromatography-triple quadrupole-tandem mass spectrometry method.
    Medina S; Miguel-Elízaga ID; Oger C; Galano JM; Durand T; Martínez-Villanueva M; Castillo ML; Villegas-Martínez I; Ferreres F; Martínez-Hernández P; Gil-Izquierdo Á
    Free Radic Biol Med; 2015 Feb; 79():154-63. PubMed ID: 25464272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urine-Based Biomarkers for Alzheimer's Disease Identified Through Coupling Computational and Experimental Methods.
    Yao F; Hong X; Li S; Zhang Y; Zhao Q; Du W; Wang Y; Ni J
    J Alzheimers Dis; 2018; 65(2):421-431. PubMed ID: 30040720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.